Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
155.92
+4.54 (3.00%)
At close: Jun 26, 2026, 4:00 PM EDT
156.29
+0.37 (0.24%)
After-hours: Jun 26, 2026, 7:20 PM EDT

BDX Revenue by Segment

Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Medical
6.08B 8.84B 11.46B 11.14B 10.77B 10.46B 10.07B 9.79B
Medical Growth
-43.53% -15.46% 13.73% 13.77% 11.41% 9.20% 6.02% 11.45%
Interventional
5.38B 5.29B 5.22B 5.11B 5.02B 5.05B 4.98B 4.92B
Interventional Growth
7.19% 4.75% 4.74% 3.78% 2.45% 5.30% 5.15% 6.35%
Life Sciences
3.39B 4.64B 5.17B 5.14B 5.14B 5.20B 5.19B 5.18B
Life Sciences Growth
-34.12% -10.87% -0.48% -0.87% -0.10% 1.58% 1.13% 1.81%
Medical Essentials
3.24B 1.60B - - - - - -
Connected Care
2.25B 1.13B - - - - - -
Biopharma Systems
1.02B 429.00M - - - - - -
Other
- - - - -67.00M -67.00M -67.00M -67.00M

Revenue by Geography

Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
United States
12.68B 12.87B 12.79B 12.49B 12.20B 11.99B 11.66B 11.43B
United States Growth
3.96% 7.30% 9.67% 9.28% 7.88% 7.74% 4.95% 7.24%
International
8.69B 9.05B 9.05B 8.90B 8.67B 8.65B 8.52B 8.40B
International Growth
0.16% 4.70% 6.27% 5.93% 3.12% 3.45% 3.11% 7.00%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.